Inspire Advisors’s ICU Medical ICUI Stock Holding History

Inspire Advisors’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,110	Closed	-$489K	–	350
2023 Q3	$489K	Buy	+4,110	New	+$613K	0.09%	134

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Inspire Advisors's ICUI Position: Q4 2023 in Review

Inspire Advisors sold out of ICU Medical (ICUI) in Q4 2023, closing a stake of 4,110 shares — an estimated $489K sold.

Inspire Advisors first reported a position in ICUI in Q3 2023 and held it in 1 quarter. The position peaked at $489K in Q3 2023. 241 funds tracked by Wall St. Rank hold ICUI as of Q4 2023.

Inspire Advisors reported no remaining ICU Medical position as of Q4 2023 after selling out during the quarter.
Inspire Advisors sold 4,110 ICU Medical shares in Q4 2023, an estimated $489K.
Inspire Advisors first reported a position in ICU Medical in Q3 2023 and held it in 1 quarter.
Inspire Advisors's ICU Medical position peaked at $489K in Q3 2023.
241 funds tracked by Wall St. Rank held ICU Medical as of Q4 2023.

Based on Inspire Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.